JP2003511014A5 - - Google Patents

Download PDF

Info

Publication number
JP2003511014A5
JP2003511014A5 JP2001526577A JP2001526577A JP2003511014A5 JP 2003511014 A5 JP2003511014 A5 JP 2003511014A5 JP 2001526577 A JP2001526577 A JP 2001526577A JP 2001526577 A JP2001526577 A JP 2001526577A JP 2003511014 A5 JP2003511014 A5 JP 2003511014A5
Authority
JP
Japan
Prior art keywords
xaa
ala
arg
leu
unsure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001526577A
Other languages
English (en)
Japanese (ja)
Other versions
JP4723144B2 (ja
JP2003511014A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/004716 external-priority patent/WO2001023427A1/en
Publication of JP2003511014A publication Critical patent/JP2003511014A/ja
Publication of JP2003511014A5 publication Critical patent/JP2003511014A5/ja
Application granted granted Critical
Publication of JP4723144B2 publication Critical patent/JP4723144B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001526577A 1999-09-29 2000-02-25 副甲状腺ホルモン(pth)のポリペプチド誘導体 Expired - Fee Related JP4723144B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15692799P 1999-09-29 1999-09-29
US60/156,927 1999-09-29
PCT/US2000/004716 WO2001023427A1 (en) 1999-09-29 2000-02-25 Polypeptide derivatives of parathyroid hormone (pth)

Publications (3)

Publication Number Publication Date
JP2003511014A JP2003511014A (ja) 2003-03-25
JP2003511014A5 true JP2003511014A5 (cg-RX-API-DMAC7.html) 2010-12-24
JP4723144B2 JP4723144B2 (ja) 2011-07-13

Family

ID=22561687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001526577A Expired - Fee Related JP4723144B2 (ja) 1999-09-29 2000-02-25 副甲状腺ホルモン(pth)のポリペプチド誘導体

Country Status (6)

Country Link
EP (2) EP2030986A1 (cg-RX-API-DMAC7.html)
JP (1) JP4723144B2 (cg-RX-API-DMAC7.html)
AT (1) ATE412670T1 (cg-RX-API-DMAC7.html)
DE (1) DE60040678D1 (cg-RX-API-DMAC7.html)
ES (1) ES2316354T3 (cg-RX-API-DMAC7.html)
WO (1) WO2001023427A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417333B1 (en) 1998-11-25 2002-07-09 The General Hospital Corporation Modified human parathyroid hormone
WO2000032771A1 (en) 1998-11-30 2000-06-08 The General Hospital Corporation Pth1r and pth3r receptors, methods and uses thereof
US7169567B1 (en) 1998-12-31 2007-01-30 The General Hospital Corporation Screening assay utilizing the PTH receptor
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US7572765B2 (en) 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
JP4541899B2 (ja) * 2003-01-24 2010-09-08 ザ ジェネラル ホスピタル コーポレイション ラクタム架橋を有する、コンホメーションが制限された副甲状腺ホルモン(pth)アナログ
BRPI0814962B8 (pt) 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
FR2940292B1 (fr) * 2008-12-23 2013-05-10 Isp Investments Inc Peptides derives d'hmg-coa reductase et composition cosmetique et/ou pharmaceutique les contenant
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
MX2011010968A (es) * 2009-04-24 2012-01-19 Cadila Healthcare Ltd Peptidos de cadena corta como agonistas de los receptores de la hormona paratiroidea (pth).
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4518526A (en) 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
IL78342A (en) 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US4761406A (en) 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
CA2045129A1 (en) 1989-02-01 1990-08-02 Alfred I. Geller Herpes simplex virus type i expression vector
SG88714A1 (en) 1989-11-06 2002-05-21 Cell Genesys Inc Production of proteins using homologous recombination
IT1238348B (it) 1989-11-16 1993-07-13 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
US5266490A (en) 1991-03-28 1993-11-30 Regeneron Pharmaceuticals, Inc. Mammalian expression vector
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5871486A (en) 1993-01-21 1999-02-16 Acumed, Inc. Variable pitch bone screw
EP0705334A1 (en) 1993-06-14 1996-04-10 Basf Aktiengesellschaft Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5656465A (en) 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
US5714353A (en) 1994-05-24 1998-02-03 Research Corporation Technologies, Inc. Safe vectors for gene therapy
US5836905A (en) 1994-06-20 1998-11-17 Lemelson; Jerome H. Apparatus and methods for gene therapy
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
JPH09157294A (ja) * 1995-06-15 1997-06-17 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5723577A (en) 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5917123A (en) 1997-03-14 1999-06-29 University Of Pittsburgh Transgenic mice containing a nucleic acid encoding tumor necrosis factor-α under the control of a cardiac specific regulatory region
US6417333B1 (en) * 1998-11-25 2002-07-09 The General Hospital Corporation Modified human parathyroid hormone

Similar Documents

Publication Publication Date Title
US20230167421A1 (en) Variants of a DNA Polymerase of the Polx Family
JP3054192B2 (ja) 副甲状腺ホルモンの製造のための組換えdna法
CA2246733C (en) Use of a pharmaceutical composition comprising an appetite-suppressing peptide
US8298789B2 (en) Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)
JP2002510494A5 (cg-RX-API-DMAC7.html)
WO2003094858A2 (en) Ctp-extended erythropoietin
CN107698684A (zh) 包含突变的免疫球蛋白Fc部分的GLP‑1融合蛋白
US20180161443A1 (en) Growth hormone polypeptides and methods of making and using same
CN111132996A (zh) 用于重组蛋白表达的融合标签
RU2000103824A (ru) Адипоцит-специфические белковые гомологи
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras
WO2002008716A3 (fr) Procede de criblage de peptides utilisables en immunotherapie
Einhauer et al. Expression and purification of homogenous proteins in Saccharomyces cerevisiae based on ubiquitin-FLAG fusion
KR20210064144A (ko) GroES 융합을 이용한 글루카곤 유사 펩타이드-1 또는 이의 유사체의 생산방법
JP2002533115A5 (cg-RX-API-DMAC7.html)
JP2003527073A5 (cg-RX-API-DMAC7.html)
CN1350584A (zh) 从新的融合蛋白制造重组胰岛素的方法
CN112105635A (zh) 用于重组蛋白的更高表达的前导序列
KR20210010365A (ko) 단백질 또는 폴리펩타이드 생산용 융합태그
US7829307B2 (en) Production of glucagon-like peptide 2
CA2381439A1 (en) Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c
USRE37919E1 (en) Recombinant DNA method for production of parathyroid hormone
Barlos et al. An optimized chemical synthesis of human relaxin‐2
CN101389649A (zh) 多肽拮抗剂
CA2315282A1 (en) Single-chain polypeptides comprising troponin i and troponin c